Format

Send to:

Choose Destination
See comment in PubMed Commons below
Breast Cancer Res. 2001;3(3):150-3. Epub 2001 Mar 28.

Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?

Author information

  • 1CRC Molecular and Cellular Pharmacology Group, School of Biological Sciences, Manchester, UK. guy.makin@man.ac.uk

Abstract

Drug resistance is a fundamental problem in the treatment of most common human cancers. Our understanding of the cellular mechanisms underlying death and survival has allowed the development of rational approaches to overcoming drug resistance. The mitogen activated protein kinase family of protein serine/threonine kinases has been implicated in this complex web of signalling, with some members acting to enhance death and other members to prevent it. A recent publication by MacKeigan et al is the first to demonstrate an enhancement of drug-induced cell death by simultaneous blockade of MEK-mediated survival signalling, and offers the potential for targeted adjuvant therapy as a means of overcoming drug resistance.

PMID:
11305949
[PubMed - indexed for MEDLINE]
PMCID:
PMC138679
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk